Rocket Lab Reality Check: Gravity Always Wins
RKLB trades at 78x sales while insiders dump $419M. With the Neutron tank rupture pushing timelines, is this SpaceX killer priced for perfection or failure?
You bought the 'SpaceX Killer' narrative at the all-time high, didn't you? Now you're holding a bag heavier than a Neutron payload while the CEO unloads his shares. It's time to stop looking at the stars and start looking at the balance sheet, sweetheart.
The Diagnosis
Verdict: Priced for Perfection / High Risk
As of Feb 6, 2026, following the Neutron tank rupture.
$RKLB appears to be suffering from a severe case of "Priced for Perfection" syndrome, complicated by acute mechanical failure. The stock is currently trading on "faith-based" multiples rather than industrial reality. Key risks include a valuation that assumes zero mistakes in an industry defined by explosions, and a timeline that just got pushed to the right.
However, the patient isn't terminal—the Space Systems organ is healthy—but the fever needs to break before recovery begins.
The Vitals
| Metric | Value | Signal |
|---|---|---|
| Revenue | $155.08M (+48% YoY) | Growing |
| Gross Margins | 37% (Record High) | Healthy |
| Insider Activity | ~$419M sold (CEO + CFO) | Bearish |
| Valuation | ~78x Sales | Extreme |
The Pathology
1. The "Hungry Hippo" Hiccup (Neutron Tank Rupture)
The Fact: During January 2026 testing, the Stage 1 tank failed under pressure—a structural flaw in the carbon composite design.
This isn't just a scratch; it's a systemic risk. Delays don't just hurt feelings; they burn cash ($500M+ on hand, but fading). If the launch slips to 2027, competitors like Relativity Space (Terran R) will eat Rocket Lab's lunch.
2. The Smart Money Exodus (Insider Selling)
The Fact: CEO Peter Beck sold ~$270M and CFO Adam Spice sold ~$150M in the last 6 months. Zero insider buys.
When the people who built the rocket are selling at the top, why are you buying? They exited into the "SpaceX IPO" hype. If they believed the $39B valuation was justified, they wouldn't be cashing out half a billion dollars collectively.
The Steel-Man (Bull Case)
Now, I know why you're in love with her. She's seductive.
If Space Systems continues to monopolize the supply chain (solar cells, reaction wheels), $RKLB becomes a "Prime" contractor, not just a taxi service. The $816M SDA Contract is real, government-backed revenue that is recession-proof. If they fix the tank by Q2 2026, that 37% margin profile could justify a premium—eventually.
But right now? That's a gamble, not an investment.
Nurse's Orders
1. Watch the $60 Support Level
This is the "breakout" zone. If price drops below $60, we could see a flush down to the 200-day moving average ($48-$50). Don't try to catch a falling knife in the "No Man's Land" between $66 and $75.
2. The Feb 26 Earnings Call is Binary
Forget the EPS beat/miss. The only thing that matters is the Neutron Schedule Update. Scenario A: Launch confirmed for 2026? Bullish resilience. Scenario B: Launch pushed to mid-2027? The multiple will compress violently.
3. Monitor the "SpaceX Halo"
Much of $RKLB's price is anchored to the rumored $1.5T SpaceX IPO. If SpaceX delays its IPO, the "scarcity premium" on RKLB evaporates. You're not just betting on Rocket Lab—you're betting on Elon's timing.
Bottom Line
The Space Systems business is real, but the Neutron dream is on life support. Wait for the Feb 26 earnings call before touching this one—gravity always wins.